Efficacy and safety of nateglinide in post-marketing surveillance studies in Japan

被引：0
|
作者：
Damholt, BB
Golor, G
Wierich, W
Pedersen, PC
Ekblom, M
Zdravkovic, M
机构：
来源：
DIABETES | 2005年 / 54卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A114 / A114
页数：1
相关论文
共 50 条
  • [1] Post-marketing surveillance of the safety of levofloxacin in Japan
    Yamaguchi, Hiroki
    Kawai, Hitomi
    Matsumoto, Takuyuki
    Yokoyama, Hiroo
    Nakayasu, Toshio
    Komiya, Masahiro
    Shimada, Jingoro
    [J]. CHEMOTHERAPY, 2007, 53 (02) : 85 - 103
  • [2] Post-Marketing Surveillance of Efficacy and Safety of Nateglinide in Combination with Metformin in Chinese Type 2 Diabetic Patients
    Yang, Jin-Kui
    Cheng, Li-Ming
    Jiang, Xia
    Han, Bao-Ling
    Zhou, Lian-Hua
    Zhao, Heng-Xia
    Liang, Jiang-Ming
    Wei, Al-Sheng
    Cai, Xin-Juan
    Zhuang, Xiao-Ming
    Ni, Qing
    He, Zhong-Chen
    Li, Hong-Mei
    Song, Xiao-Min
    Lu, Guano-Hua
    Yu, Ming
    Yang, Jia-Lin
    Ji, Qiu-Di
    Xu, Yuan
    Lu, Hao
    Liu, Wei
    Cai, De-Hong
    Li, Yan-Bing
    [J]. DIABETES, 2010, 59 : A568 - A569
  • [3] Characteristics of post-marketing studies and their contribution to post-marketing safety measures in Japan
    Kanmuri K.
    Narukawa M.
    [J]. Pharmaceutical Medicine, 2014, 28 (2) : 67 - 73
  • [4] Efficacy and safety of ibrutinib in relapsed/refractory CLL and SLL in Japan: a post-marketing surveillance
    Omi, Ai
    Nomura, Fumi
    Tsujioka, Shigeharu
    Fujino, Akiko
    Akizuki, Reiko
    [J]. JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2022, 62 (03) : 136 - 146
  • [5] POST-MARKETING SURVEILLANCE OF OFLOXACIN IN JAPAN
    YAMADA, A
    NAKAMURA, S
    TAKAHASHI, K
    SAWADA, M
    OKADA, S
    [J]. REVIEWS OF INFECTIOUS DISEASES, 1989, 11 : S1409 - S1409
  • [6] Post-marketing device safety surveillance
    Vidi, Venkatesan D.
    Matheny, Michael E.
    Resnic, Frederic S.
    [J]. CONTEMPORARY CLINICAL TRIALS, 2011, 32 (03) : 307 - 308
  • [7] Efficacy and safety of adalimumab treatment in psoriasis with psoriatic arthritis: Result from post-marketing surveillance in Japan
    Asahina, A.
    Toril, H.
    Ohtsuki, M.
    Sawa, J.
    Yamaguchi, Y.
    Nakagawa, H.
    [J]. JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2014, 134 : S90 - S90
  • [8] Drug use investigation on the safety and efficacy of tigecycline in Japan (all-case post-marketing surveillance)
    Ohashi, Takahisa
    Sugiyama, Noriko
    Watanabe, Toshiya
    Uryu, Taku
    Yoshinaga, Yukari
    [J]. JOURNAL OF INFECTION AND CHEMOTHERAPY, 2022, 28 (07) : 866 - 874
  • [9] Safety analysis of Epzicom ® (lamivudine/abacavir sulfate) in post-marketing surveillance in Japan
    Kurita, Tomoko
    Kitaichi, Tomomi
    Nagao, Takako
    Miura, Toshiyuki
    Kitazono, Yoshifumi
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2014, 23 (04) : 372 - 381
  • [10] Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan
    Kawasaki, Akira
    Hatake, Kiyohiko
    Matsumura, Itaru
    Izutsu, Koji
    Hoshino, Tomohiro
    Akamatsu, Ayumi
    Kakuuchi, Akito
    Tobinai, Kensei
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2024, 119 (06) : 667 - 676
12345